These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 20465658)

  • 1. Prevention and treatment of systemic glucocorticoid side effects.
    Moghadam-Kia S; Werth VP
    Int J Dermatol; 2010 Mar; 49(3):239-48. PubMed ID: 20465658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and treatment of glucocorticoid-induced osteoporosis in daily dermatologic practice.
    Vermaat H; Kirtschig G
    Int J Dermatol; 2008 Jul; 47(7):737-42. PubMed ID: 18613886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suggested rationale for prevention and treatment of glucocorticoid-induced bone loss in dermatologic patients.
    Yosipovitch G; Hoon TS; Leok GC
    Arch Dermatol; 2001 Apr; 137(4):477-81. PubMed ID: 11295929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic glucocorticoids: important issues and practical guidelines for the dermatologist.
    Dodiuk-Gad RP; Ish-Shalom S; Shear NH
    Int J Dermatol; 2015 Jun; 54(6):723-9. PubMed ID: 25683616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid-induced bone loss in dermatologic patients: an update.
    Summey BT; Yosipovitch G
    Arch Dermatol; 2006 Jan; 142(1):82-90. PubMed ID: 16415391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventive techniques to limit glucocorticoid-induced side effects.
    Vittorio CC; Werth VP
    Adv Dermatol; 2000; 16():273-97; discussion 298. PubMed ID: 11094631
    [No Abstract]   [Full Text] [Related]  

  • 7. Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events.
    Fardet L; Fève B
    Drugs; 2014 Oct; 74(15):1731-45. PubMed ID: 25204470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
    Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroids: a review with emphasis on complications of prolonged systemic therapy.
    Truhan AP; Ahmed AR
    Ann Allergy; 1989 May; 62(5):375-91. PubMed ID: 2655506
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention and treatment of glucocorticoid-induced osteoporosis. A pathogenetic perspective.
    Libanati CR; Baylink DJ
    Chest; 1992 Nov; 102(5):1426-35. PubMed ID: 1424863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and management of glucocorticoid-induced side effects: A comprehensive review: A review of glucocorticoid pharmacology and bone health.
    Caplan A; Fett N; Rosenbach M; Werth VP; Micheletti RG
    J Am Acad Dermatol; 2017 Jan; 76(1):1-9. PubMed ID: 27986132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid-induced osteoporosis in dermatologic practice: a review.
    Khan YK; Kalaaji AN; Clarke BL
    J Drugs Dermatol; 2008 Nov; 7(11):1053-9. PubMed ID: 19110736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term side effects of glucocorticoids.
    Oray M; Abu Samra K; Ebrahimiadib N; Meese H; Foster CS
    Expert Opin Drug Saf; 2016; 15(4):457-65. PubMed ID: 26789102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on glucocorticoid-induced osteoporosis.
    Woolf AD
    Curr Opin Rheumatol; 2007 Jul; 19(4):370-5. PubMed ID: 17551369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immobility in the aged.
    Rousseau P
    Arch Fam Med; 1993 Feb; 2(2):169-77; discussion 178. PubMed ID: 8275186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroid-induced osteoporosis: an update for dermatologists.
    Clarke BL
    Am J Clin Dermatol; 2012 Jun; 13(3):167-90. PubMed ID: 22393910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Major side effects of systemic glucocorticoid].
    Kudo C
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():317-21. PubMed ID: 25831775
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic corticosteroid therapy--side effects and their management.
    Stanbury RM; Graham EM
    Br J Ophthalmol; 1998 Jun; 82(6):704-8. PubMed ID: 9797677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safe and appropriate use of systemic glucocorticoids in treating dermatologic disease.
    Werth VP
    J Am Acad Dermatol; 2013 Jan; 68(1):177-8. PubMed ID: 23244375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.